The trial to set a suitable period of using esomeprazole to cure the gastric ulcer after endoscopic submucosal dissection (ESD) for mucosal cancers of the stomach.

The trial to set a suitable period of using esomeprazole to cure the gastric ulcer after endoscopic submucosal dissection (ESD) for mucosal cancers of the stomach. - The trial to set a suitable period of using esomeprazole to cure the gastric ulcer after endoscopic submucosal disssection (ESD) for mucosal cancers of the stomach.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000008271

Enrollment

Registered

2012-06-27

Start date

2012-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mucosal cancer of the stomach

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were resected the mucosal cancer of the stomack by endoscopic submucosal resection (ESD).

Exclusion criteria

Exclusion criteria: 1)Hypersensitivity of Esomeprazole 2)Taking the medicine which is prohibited to take together with Esomeprazole 3)Under pregnancy or breast-feeding 4)Impossibility of oral intake 5)Past history of resection of upper GI 6)Taking medicines which are possible to interact with Esomeprazole

Design outcomes

Primary

Measure	Time frame
A period to cure the ESD ulcer in the stomach.	—

Secondary

Measure	Time frame
A period required to cure the ESD ulcer relative to its location and size, respectively. A rate of the ulcer healing at the time of 4 weeks, 6 weeks, and 8 weeks after ESD, respectively. A rate of the ulcer shrinkage at the time of 4 weeks, 6 weeks, and 8 weeks after ESD, respectively.	—

Countries

Japan

Contacts

Public ContactEri Uchida

Machida municipal hospital Department of Gastroenterology

eri_uchida0713@yahoo.co.jp042-722-2230

Outcome results